Drug · DIN 02436558
FERRIPROX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 12, 2020; first marketed April 28, 2015.
- Drug Identification Number (DIN)
- 02436558
- Company (DIN owner)
- Chiesi Canada Corp.Woodbridge, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Deferiprone V03AC02
- Class
- Human
- Record last updated
- September 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEFERIPRONE | 1000 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 12, 2020: NOC 23334New Drug Submission (NDS) · Administrative: Change in Product Ownership
- February 13, 2015: NOC 16598New Drug Submission (NDS)
Other DINs named FERRIPROX
- DIN 02436523 · Marketed
- DIN 02436531 · Marketed